Potential pathogenic and protective genotypes and phenotypes of vitamin D binding protein in multiple sclerosis

BackgroundThe main carrier protein of vitamin D and its metabolites in plasma is vitamin D binding protein (VDBP) or group-specific component (Gc). Two single nucleotide polymorphisms, rs7041, and rs4588 in the GC gene result in three major VDBP/Gc genotypes, GC1F (c.1296T, c.1307C), GC1S (c.1296G,...

Full description

Saved in:
Bibliographic Details
Main Authors: Suhail Al-Shammri, Arpita Chattopadhyay, Abu Salim Mustafa
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1455779/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206831987818496
author Suhail Al-Shammri
Suhail Al-Shammri
Arpita Chattopadhyay
Abu Salim Mustafa
author_facet Suhail Al-Shammri
Suhail Al-Shammri
Arpita Chattopadhyay
Abu Salim Mustafa
author_sort Suhail Al-Shammri
collection DOAJ
description BackgroundThe main carrier protein of vitamin D and its metabolites in plasma is vitamin D binding protein (VDBP) or group-specific component (Gc). Two single nucleotide polymorphisms, rs7041, and rs4588 in the GC gene result in three major VDBP/Gc genotypes, GC1F (c.1296T, c.1307C), GC1S (c.1296G, c.1307C), GC2 (c.1296T, c.1307A), and phenotypes, Gc1F (p.432Asp, p.436Thr), Gc1S (p.432Glu, p.436Thr), and Gc2 (p.432Asp, p.436Lys). This study investigated frequencies of GC genotypes and phenotypes in Kuwaiti multiple sclerosis (MS) patients and healthy controls, and their associations with serum levels of 25 hydroxyvitamin D [25(OH)vitamin D] and VDBP.MethodsThe genomic DNA was isolated from blood samples of drug-naïve MS patients (N = 151) and controls (N = 127). DNA regions covering the targeted mutations were amplified by PCR, sequenced by the Sanger method, and analyzed to determine GC genotypes and phenotypes. Serum 25(OH)vitamin D and VDBP levels were measured by enzyme immunoassay. SPSS used for statistical analyses. Differences between independent and related groups tested by Mann–Whitney U and Wilcoxon signed-rank tests respectively, Genotype and phenotype frequencies were calculated; p < 0.05 considered significant.ResultsThe study detected four Gc genotypes/phenotypes, namely GC1F/Gc1F (c.1296T, c.1307C/p.432Asp, p.436Thr), GC1S/Gc1S (c.1296G, c.1307C/p.432Glu, p.436Thr), GC2/Gc2 (c.1296T, c.1307A/p.432Asp, p.436Lys), and GC3/Gc3 (c.1296G; c.1307A/p.432Glu, p.436Lys) in both subjects. The frequencies of GC3 genotype (control: 5.51%; patient: 28.48%) and Gc3-containing phenotypic groups (Gc1S/Gc3 + Gc2/Gc3 + Gc3/Gc3) were significantly higher in patients. Moreover, frequencies of GC1F genotype (control: 27.17%; patients: 5.30%) and Gc1F-containing phenotypic groups (Gc1F/Gc1F + Gc1S/Gc1F + Gc2/Gc1F) were higher in controls. Vitamin D levels were deficient in both groups. However, VDBP concentrations were significantly low in MS patients only.ConclusionThe VDBP/GC genotypes and phenotypes are associated with MS. Common genotype GC1F might be protective, and GC3, the novel variant found in MS patients appeared to be pathogenetic. Hypovitaminosis-D is prevalent in MS patients and controls.
format Article
id doaj-art-e6441eb18f8347c088b21c260c172a1b
institution Kabale University
issn 1664-2295
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj-art-e6441eb18f8347c088b21c260c172a1b2025-02-07T05:10:33ZengFrontiers Media S.A.Frontiers in Neurology1664-22952025-02-011610.3389/fneur.2025.14557791455779Potential pathogenic and protective genotypes and phenotypes of vitamin D binding protein in multiple sclerosisSuhail Al-Shammri0Suhail Al-Shammri1Arpita Chattopadhyay2Abu Salim Mustafa3Department of Medicine, College of Medicine, Kuwait University, Jabriya, KuwaitDepartment of Medicine, Mubarak Al Kabeer Hospital, Ministry of Health, Jabriya, KuwaitDepartment of Medicine, College of Medicine, Kuwait University, Jabriya, KuwaitDepartment of Microbiology, College of Medicine, Kuwait University, Jabriya, KuwaitBackgroundThe main carrier protein of vitamin D and its metabolites in plasma is vitamin D binding protein (VDBP) or group-specific component (Gc). Two single nucleotide polymorphisms, rs7041, and rs4588 in the GC gene result in three major VDBP/Gc genotypes, GC1F (c.1296T, c.1307C), GC1S (c.1296G, c.1307C), GC2 (c.1296T, c.1307A), and phenotypes, Gc1F (p.432Asp, p.436Thr), Gc1S (p.432Glu, p.436Thr), and Gc2 (p.432Asp, p.436Lys). This study investigated frequencies of GC genotypes and phenotypes in Kuwaiti multiple sclerosis (MS) patients and healthy controls, and their associations with serum levels of 25 hydroxyvitamin D [25(OH)vitamin D] and VDBP.MethodsThe genomic DNA was isolated from blood samples of drug-naïve MS patients (N = 151) and controls (N = 127). DNA regions covering the targeted mutations were amplified by PCR, sequenced by the Sanger method, and analyzed to determine GC genotypes and phenotypes. Serum 25(OH)vitamin D and VDBP levels were measured by enzyme immunoassay. SPSS used for statistical analyses. Differences between independent and related groups tested by Mann–Whitney U and Wilcoxon signed-rank tests respectively, Genotype and phenotype frequencies were calculated; p < 0.05 considered significant.ResultsThe study detected four Gc genotypes/phenotypes, namely GC1F/Gc1F (c.1296T, c.1307C/p.432Asp, p.436Thr), GC1S/Gc1S (c.1296G, c.1307C/p.432Glu, p.436Thr), GC2/Gc2 (c.1296T, c.1307A/p.432Asp, p.436Lys), and GC3/Gc3 (c.1296G; c.1307A/p.432Glu, p.436Lys) in both subjects. The frequencies of GC3 genotype (control: 5.51%; patient: 28.48%) and Gc3-containing phenotypic groups (Gc1S/Gc3 + Gc2/Gc3 + Gc3/Gc3) were significantly higher in patients. Moreover, frequencies of GC1F genotype (control: 27.17%; patients: 5.30%) and Gc1F-containing phenotypic groups (Gc1F/Gc1F + Gc1S/Gc1F + Gc2/Gc1F) were higher in controls. Vitamin D levels were deficient in both groups. However, VDBP concentrations were significantly low in MS patients only.ConclusionThe VDBP/GC genotypes and phenotypes are associated with MS. Common genotype GC1F might be protective, and GC3, the novel variant found in MS patients appeared to be pathogenetic. Hypovitaminosis-D is prevalent in MS patients and controls.https://www.frontiersin.org/articles/10.3389/fneur.2025.1455779/fullmultiple sclerosisvitamin D binding proteinpolymorphismgeneticvitamin DKuwait
spellingShingle Suhail Al-Shammri
Suhail Al-Shammri
Arpita Chattopadhyay
Abu Salim Mustafa
Potential pathogenic and protective genotypes and phenotypes of vitamin D binding protein in multiple sclerosis
Frontiers in Neurology
multiple sclerosis
vitamin D binding protein
polymorphism
genetic
vitamin D
Kuwait
title Potential pathogenic and protective genotypes and phenotypes of vitamin D binding protein in multiple sclerosis
title_full Potential pathogenic and protective genotypes and phenotypes of vitamin D binding protein in multiple sclerosis
title_fullStr Potential pathogenic and protective genotypes and phenotypes of vitamin D binding protein in multiple sclerosis
title_full_unstemmed Potential pathogenic and protective genotypes and phenotypes of vitamin D binding protein in multiple sclerosis
title_short Potential pathogenic and protective genotypes and phenotypes of vitamin D binding protein in multiple sclerosis
title_sort potential pathogenic and protective genotypes and phenotypes of vitamin d binding protein in multiple sclerosis
topic multiple sclerosis
vitamin D binding protein
polymorphism
genetic
vitamin D
Kuwait
url https://www.frontiersin.org/articles/10.3389/fneur.2025.1455779/full
work_keys_str_mv AT suhailalshammri potentialpathogenicandprotectivegenotypesandphenotypesofvitamindbindingproteininmultiplesclerosis
AT suhailalshammri potentialpathogenicandprotectivegenotypesandphenotypesofvitamindbindingproteininmultiplesclerosis
AT arpitachattopadhyay potentialpathogenicandprotectivegenotypesandphenotypesofvitamindbindingproteininmultiplesclerosis
AT abusalimmustafa potentialpathogenicandprotectivegenotypesandphenotypesofvitamindbindingproteininmultiplesclerosis